Ipratropium Bromide Aerosol :for treatment of bronchospasm associated with moderate to severe chronic obstruction airway disease.Indications: It is indicated as bronchodilator for treatment of bronchospasm associated with moderate to severe chronic obstruction airway disease.

Dosage and administration:It is for oral inhalation use only.

Adults: Two inhalations four times a day. The dose may be increased as required up to a limit of 12 inhalations in 24 hours. Children: Not recommended for children under 12 years of age. Patients should be advised to consult a doctor or the nearest hospital immediately in the case of acute or rapidly worsening dyspnoea (difficulty in breathing) if additional inhalations do not produce an adequate improvement. Contraindications: It is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine or its derivatives.

PRESENTATION20mcg per actuation, 200 actuations per bottle.

MANUFACTURER Jewim Pharmaceutical (Shandong) Co., Ltd.